146 related articles for article (PubMed ID: 33581150)
1. Shared Decision Making in Early-Stage Non-small Cell Lung Cancer: A Systematic Review.
Dalmia S; Boele F; Absolom K; Brunelli A; Franks K; Bekker HL; Pompili C
Ann Thorac Surg; 2022 Aug; 114(2):581-590. PubMed ID: 33581150
[TBL] [Abstract][Full Text] [Related]
2. Treatment recommendations by clinicians in stage I non-small cell lung cancer: A study of factors that influence the likelihood of accounting for the patient's preference.
Hopmans W; Damman OC; Porsius JT; Zwaan L; Senan S; Timmermans DR
Patient Educ Couns; 2016 Nov; 99(11):1808-1813. PubMed ID: 27372523
[TBL] [Abstract][Full Text] [Related]
3. A patient perspective on shared decision making in stage I non-small cell lung cancer: a mixed methods study.
Hopmans W; Damman OC; Senan S; Hartemink KJ; Smit EF; Timmermans DR
BMC Cancer; 2015 Dec; 15():959. PubMed ID: 26673216
[TBL] [Abstract][Full Text] [Related]
4. Treatment selection of early stage non-small cell lung cancer: the role of the patient in clinical decision making.
Mokhles S; Nuyttens JJME; de Mol M; Aerts JGJV; Maat APWM; Birim Ö; Bogers AJJC; Takkenberg JJM
BMC Cancer; 2018 Jan; 18(1):79. PubMed ID: 29334910
[TBL] [Abstract][Full Text] [Related]
5. Stereotactic radiotherapy (SABR) for the treatment of primary non-small cell lung cancer; systematic review and comparison with a surgical cohort.
Soldà F; Lodge M; Ashley S; Whitington A; Goldstraw P; Brada M
Radiother Oncol; 2013 Oct; 109(1):1-7. PubMed ID: 24128806
[TBL] [Abstract][Full Text] [Related]
6. Differences between pulmonologists, thoracic surgeons and radiation oncologists in deciding on the treatment of stage I non-small cell lung cancer: A binary choice experiment.
Hopmans W; Zwaan L; Senan S; van der Wulp I; Damman OC; Hartemink KJ; Smit EF; Timmermans DR
Radiother Oncol; 2015 Jun; 115(3):361-6. PubMed ID: 26036595
[TBL] [Abstract][Full Text] [Related]
7. 7-year follow-up after stereotactic ablative radiotherapy for patients with stage I non-small cell lung cancer: Results of a phase 2 clinical trial.
Sun B; Brooks ED; Komaki RU; Liao Z; Jeter MD; McAleer MF; Allen PK; Balter PA; Welsh JD; O'Reilly MS; Gomez D; Hahn SM; Roth JA; Mehran RJ; Heymach JV; Chang JY
Cancer; 2017 Aug; 123(16):3031-3039. PubMed ID: 28346656
[TBL] [Abstract][Full Text] [Related]
8. Patients' confidence in treatment decisions for early stage non-small cell lung cancer (NSCLC).
Pompili C; Holch P; Rogers Z; Absolom K; Clayton B; Franks K; Bekker H; Velikova G
Health Qual Life Outcomes; 2020 Jul; 18(1):237. PubMed ID: 32682425
[TBL] [Abstract][Full Text] [Related]
9. Measuring the Integration of Stereotactic Ablative Radiotherapy Plus Surgery for Early-Stage Non-Small Cell Lung Cancer: A Phase 2 Clinical Trial.
Palma DA; Nguyen TK; Louie AV; Malthaner R; Fortin D; Rodrigues GB; Yaremko B; Laba J; Kwan K; Gaede S; Lee T; Ward A; Warner A; Inculet R
JAMA Oncol; 2019 May; 5(5):681-688. PubMed ID: 30789648
[TBL] [Abstract][Full Text] [Related]
10. Opinions of lung cancer clinicians on shared decision making in early-stage non-small-cell lung cancer.
Mokhles S; Maat APWM; Aerts JGJV; Nuyttens JJME; Bogers AJJC; Takkenberg JJM
Interact Cardiovasc Thorac Surg; 2017 Aug; 25(2):278-284. PubMed ID: 28449093
[TBL] [Abstract][Full Text] [Related]
11. Clinician perspectives on clinical decision support systems in lung cancer: Implications for shared decision-making.
Ankolekar A; van der Heijden B; Dekker A; Roumen C; De Ruysscher D; Reymen B; Berlanga A; Oberije C; Fijten R
Health Expect; 2022 Aug; 25(4):1342-1351. PubMed ID: 35535474
[TBL] [Abstract][Full Text] [Related]
12. Stereotactic Ablative Body Radiotherapy Versus Radical Radiotherapy: Comparing Real-World Outcomes in Stage I Lung Cancer.
Phillips I; Sandhu S; Lüchtenborg M; Harden S
Clin Oncol (R Coll Radiol); 2019 Oct; 31(10):681-687. PubMed ID: 31377081
[TBL] [Abstract][Full Text] [Related]
13. Lobectomy versus stereotactic ablative radiotherapy for medically operable patients with stage IA non-small cell lung cancer: A virtual randomized phase III trial stratified by age.
Seo YS; Kim HJ; Wu HG; Choi SM; Park S
Thorac Cancer; 2019 Jun; 10(6):1489-1499. PubMed ID: 31124275
[TBL] [Abstract][Full Text] [Related]
14. Is stereotactic ablative radiotherapy equivalent to sublobar resection in high-risk surgical patients with stage I non-small-cell lung cancer?
Mahmood S; Bilal H; Faivre-Finn C; Shah R
Interact Cardiovasc Thorac Surg; 2013 Nov; 17(5):845-53. PubMed ID: 23900381
[TBL] [Abstract][Full Text] [Related]
15. Quality of Life After Stereotactic Ablative Radiotherapy for Early-Stage Lung Cancer: A Systematic Review.
Chen H; Louie AV; Boldt RG; Rodrigues GB; Palma DA; Senan S
Clin Lung Cancer; 2016 Sep; 17(5):e141-e149. PubMed ID: 26791542
[TBL] [Abstract][Full Text] [Related]
16. Management of early-stage non-small cell lung cancer using stereotactic ablative radiotherapy: controversies, insights, and changing horizons.
Louie AV; Palma DA; Dahele M; Rodrigues GB; Senan S
Radiother Oncol; 2015 Feb; 114(2):138-47. PubMed ID: 25497873
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of a National Comprehensive Cancer Network Guidelines-Based Decision Support Tool in Patients With Non-Small Cell Lung Cancer: A Nonrandomized Clinical Trial.
Wu SY; Lazar AA; Gubens MA; Blakely CM; Gottschalk AR; Jablons DM; Jahan TM; Wang VEH; Dunbar TL; Wong ML; Chan JW; Guthrie W; Belkora J; Yom SS
JAMA Netw Open; 2020 Sep; 3(9):e209750. PubMed ID: 32997124
[TBL] [Abstract][Full Text] [Related]
18. Post-treatment survival difference between lobectomy and stereotactic ablative radiotherapy in stage I non-small cell lung cancer in England.
Khakwani A; Harden S; Beckett P; Baldwin D; Navani N; West D; Hubbard R
Thorax; 2020 Mar; 75(3):237-243. PubMed ID: 31879316
[TBL] [Abstract][Full Text] [Related]
19. Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials.
Chang JY; Senan S; Paul MA; Mehran RJ; Louie AV; Balter P; Groen HJ; McRae SE; Widder J; Feng L; van den Borne BE; Munsell MF; Hurkmans C; Berry DA; van Werkhoven E; Kresl JJ; Dingemans AM; Dawood O; Haasbeek CJ; Carpenter LS; De Jaeger K; Komaki R; Slotman BJ; Smit EF; Roth JA
Lancet Oncol; 2015 Jun; 16(6):630-7. PubMed ID: 25981812
[TBL] [Abstract][Full Text] [Related]
20. Patient-reported Outcomes After the Treatment of Early Stage Non-small-cell Lung Cancer With Stereotactic Body Radiotherapy Compared With Surgery.
Alberts L; Wolff HB; Kastelijn EA; Lagerwaard FJ; Hofman FN; Sharouni SYE; Schramel FMNH; Coupe VMH
Clin Lung Cancer; 2019 Sep; 20(5):370-377.e3. PubMed ID: 31182416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
